Supplier Stories for the Week of January 7

Here’s what was new in the world of medical device suppliers during the week of January 7.

  • This is a compilation of the latest news from suppliers in the medical device industry. If you have news you’d like to submit for potential inclusion in this weekly roundup, please send a press release and any related images to [email protected] with the subject line “Supplier Stories.”

    [Image courtesy of STUART MILES/FREEDIGITALPHOTOS.NET]

  • Natvar, a Tekni-Plex business unit, will be showcasing its medical tubing innovations at Booth #2027 at MD&M West, February 6-8, in Anaheim. Natvar microextrudes monolayer, coextruded, multi-lumen tubing, and profiles in a variety of thermoplastic (PVC, urethanes, TPEs) materials and wall thicknesses ranging from 0.003 to 0.005 inches. The company is also making globally available its high-precision medical silicone extrusion tubing, typically used for catheters, feeding tubes, drug delivery, and peristaltic pump applications.

    Production for microextrusion and silicone tubing at the company's new China manufacturing plant is scheduled to go on stream in February.

    [Image courtesy NATVAR, A TEKNI-PLEX BUSINESS UNIT]

  • Intertronics has issued a free guide on some of the differences between conventional UV curing lamps and the latest LED technology lamps. Using UV light to cure materials such as adhesives, coating, encapsulants, potting compounds, temporary masking materials, or gaskets can provide many process advantages, the company reports in a news release. Delivering a full cure in seconds (rather than minutes or hours) is a prime example, it says.

    "Top Tips for Getting the Best from your UV Curing Process" aims to help readers better understand how UV curing works.  "A good grasp of the fundamentals will help engineers, technicians, and operators to set up an established process which is effective, robust, and repeatable," the company reports. 

    [Image courtesy of INTERTRONICS]

  • Traco Power introduces the THM 20WI family of medical 20 Watt DC/DC converters with ultra-wide 4:1 input range in a 1.0 x 1.6 X 0.40 in. footprint. Appropriate for medical equipment, the 20 Watt DC-DC converters provide reinforced insulation with high isolation of 5,000VACrms (250VACrms working voltage) and low leakage of less than 2.5uA, the company reports in a press release. All models are certified to ANSI/AAMI ES 60601-1:2005/(R)2012 3rd Edition for 2xMOPP compliance and are suitable for BF rated applications.

    Other features reported include: extended -40 to +80C operating temperature range (full power to +55C); efficiencies up to 89.5%; +/- 10% voltage trim range; EMC compliance to IEC60601-1 4th edition and EN55032 Class A; operating altitude up to 5000m; under-voltage lock-out; overload protection; and short-circuit protection.

    All models are manufactured per ISO 14971, ISO 13485 and manufactured according to IPC-A-610 Level 3 standards.

    [Image courtesy of TRACO POWER]

  • AGC Chemicals Americas Inc. will be featuring Amolea AT2, a fluorinated precision cleaning solvent offering medical device manufacturers an alternative to n-propyl bromide and trichloroethylene solvents, at MD&M West 2018, Booth 2360, February 6-8. 

    Amolea AT2 has no ozone depletion potential, offers low global warming potential, and is non-flammable, enabling manufacturers to more easily meet increasingly strict environmental regulations, the company reports in a news release. The solvent is approved for use as a precision cleaner, defluxing agent, carrier solvent for silicone and fluorinated lubricants, and moisture displacement fluid.

    “Amolea AT2 is an ideal cleaning solvent for medical device manufacturers because it lets them comply with environmental regulations more easily and helps them to improve worker health and safety,” said Jim Scott, AGC technical manager, in the release. 

    The company also offers the AsahiKlin AE-3000 series of environmentally sensible fluorinated solvents, which were designed to replace halogenated solvents having unfavorable environmental properties.

    [Image courtesy of AGC CHEMICALS AMERICAS INC.]

  • Enable Injections Inc. has achieved ISO 13485:2016 certification for its Quality Management Systems The company develops the advanced enFuse large volume wearable injectors (LVWI) platform for subcutaneous delivery of biologics.

    “As demand for our enFuse drug delivery platform accelerates, our pharma partners can be assured that Enable Injections is committed to designing and manufacturing the highest quality, most advanced and most patient-friendly biologics delivery technology,” said Michael D. Hooven, Enable Injections President and CEO, in a news release. “With our pharma partners, we are dedicated to radically improving the patient infusion experience to increase compliance, improve outcomes, and reduce health system costs.”

    Enable’s wearable devices offer the potential to shift treatment to the patient’s home or office by providing easy and comfortable patient self-administration of doses as large as 50 ml, the company reports. The company was founded by medical device industry veterans; devices are available for pharmaceutical and biotechnology industry investigational use. 

    [Image courtesy of ENABLE INJECTIONS]

Daphne Allen

Daphne Allen is editor-in-chief of MD+DI. She previously served as executive editor of Pharmaceutical & Medical Packaging News, which serves as the pharmaceutical and medical device channel of Packaging Digest. Daphne has covered medical device packaging, labeling, manufacturing, and regulatory issues as well as pharmaceutical packaging for more than 20 years. She is also a member of the Institute of Packaging Professionals's Medical Device Packaging Technical Committee. Follow her on Twitter at @daphneallen.

 

500 characters remaining